Canopy Growth (CGC) Cash from Operations (QoQ) (2019 - 2024)
Canopy Growth (CGC) Cash from Operations (QoQ) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn |
| 3 | Zoetis | 32.69 Bn | 30.75 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.61 Bn | 23.55 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.53 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Canopy Growth | 273.16 Mn | 7.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 51.10% |
| Sep 30, 2024 | -4.27% |
| Jun 30, 2024 | -131.26% |
| Mar 31, 2024 | 31.57% |
| Dec 31, 2023 | 73.52% |
| Sep 30, 2023 | -14.24% |
| Jun 30, 2023 | -557.12% |
| Mar 31, 2023 | 111.98% |
| Dec 31, 2022 | -131.95% |
| Sep 30, 2022 | 43.49% |
| Jun 30, 2022 | -414.01% |
| Mar 31, 2022 | 83.85% |
| Dec 31, 2021 | -94.44% |
| Sep 30, 2021 | 49.36% |
| Jun 30, 2021 | -74.48% |
| Mar 31, 2021 | -15.03% |
| Dec 31, 2020 | 44.64% |
| Sep 30, 2020 | -41.97% |
| Jun 30, 2020 | 45.58% |
| Mar 31, 2020 | -9.22% |